Physician profile
John Bondhus
NPI 1679641997
$905.43
in general payments reported to CMS, 2019-2025
11 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $228 · 2022: $234 · 2023: $190 · 2024: $87.36 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $443.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $226.25 | 2023-2024 | Invega Sustenna, Invega Trinza |
| Astrazeneca Pharmaceuticals LP | $209.67 | 2021-2025 | Airsupra |
| Vertex Pharmaceuticals Incorporated | $120.58 | 2025 | |
| Emd Serono, INC. | $120.07 | 2022 | |
| Alexion Pharmaceuticals, INC. | $102.24 | 2022 | |
| Genentech USA, INC. | $32.97 | 2021-2022 | |
| Pfizer INC. | $29.99 | 2024-2025 | |
| Abbott Laboratories | $18.72 | 2024 | Freestyle Libre 3 |
| Exact Sciences Corporation | $18.06 | 2024 | Cologuard Collection Kit |
| Boston Scientific Corporation | $15.65 | 2021 | |
| Ironwood Pharmaceuticals, INC | $11.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bondhus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.